Patents by Inventor Sean Saint

Sean Saint has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220347390
    Abstract: Systems, devices, and techniques are disclosed for administering and tracking medicine to patients and providing health management capabilities for patients and caregivers. In some aspects, an intelligent medicine administering system includes a medicine injection device having a multi-channel encoder that detects fault conditions (e.g., such as open or short circuits) and a patient user's companion device including a software application operable to implement algorithms for detecting faults and communication loss and alerting the patient user for safety and fail-safes of the medicine injection device.
    Type: Application
    Filed: June 22, 2022
    Publication date: November 3, 2022
    Inventors: Sean Saint, Jack Pryor, Arnold Holmquist
  • Patent number: 11484657
    Abstract: Systems, devices, and techniques are disclosed for administering and tracking medicine to patients and providing health management capabilities for patients and caregivers. In some aspects, a system includes an injection pen device including a dose setting mechanism, a dispensing mechanism, and an electronics unit to generate dose data associated with a dispensing event of a dose of the medicine dispensed from the injection pen device and time data associated with the dispensing event; a mobile device in wireless communication to receive and process the dose data; and a software application configured to determine a recommended dose based on health data and contextual data associated with a user of the injection pen device, the software application including a learning dose calculator module to adaptively calculate the recommended dose of the medicine based on time-relevant and circumstances-relevant data specific to the user of the injection pen device.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: November 1, 2022
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Sean Saint, Mike Mensinger, Arnold Holmquist, Jack Pryor
  • Patent number: 11382539
    Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into a host's peripheral vein or artery.
    Type: Grant
    Filed: October 11, 2019
    Date of Patent: July 12, 2022
    Assignee: DexCom, Inc.
    Inventors: Mark Brister, Sean Saint, Vance Swanson, Nelson Quintana
  • Patent number: 11383027
    Abstract: A system and method can provide for a remote electronic device to be used to remotely initiate delivery of a medicament bolus with a medical device, such as an insulin pump, with the medical device providing audible or tactile confirmation of the programmed bolus. The bolus amount can be calculated by or programmed or otherwise entered into the smartphone, etc., and then transmitted to the medical device. When the pump receives the transmitted bolus amount, it issues one or more indications such as audible sounds and/or vibrations in any number of desired combinations. For instance, each individual sound or vibration may correspond to an increment of the medicament. The user can therefore determine the size of the medicament bolus by the number of sounds or vibrations and can confirm or cancel delivery of the bolus.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: July 12, 2022
    Assignee: Tandem Diabetes Care, Inc.
    Inventor: Sean Saint
  • Publication number: 20220211944
    Abstract: Disclosed are systems and methods for determining a dose of insulin that compensates for past carbohydrates consumed, adjusts for blood glucose (BG) trend as well as BG value, and mitigates potential inaccuracies associated with double-counting or overcorrecting, where safeguards are applied to the determination of the insulin dose.
    Type: Application
    Filed: May 8, 2020
    Publication date: July 7, 2022
    Inventors: Michael Mensinger, Jasper Benke, Sean Saint, Jack Pryor, Angela Gaetano
  • Publication number: 20220208329
    Abstract: Systems, devices, and techniques are disclosed for differentiating a therapeutic dose and a priming event to properly administer medication to patients. In one example aspect, a method for differentiating therapeutic doses and priming events in administering a medication to a patient includes determining a time window for monitoring dispensing of the medication by an injection pen device. Multiple dispense events each releasing an amount of the medication occur in the time window. The method also includes classifying dispense events prior to a last dispense event in the time window as priming events or therapeutic doses and designating the last dispense event in the time window as a therapeutic dose for facilitating calculation and tracking of a dosage amount for the patient.
    Type: Application
    Filed: April 17, 2020
    Publication date: June 30, 2022
    Inventors: Michael Mensinger, Jack Pryor, Angela Gaetano, Sean Saint, Andrew Childs, Haripriyan Hampapuram, Arnold Holmquist, Heung Yong Im, Madison Smith
  • Patent number: 11369743
    Abstract: Systems, devices, and techniques are disclosed for administering and tracking medicine to patients and providing health management capabilities for patients and caregivers. In some aspects, an intelligent medicine administering system includes a medicine injection device having a multi-channel encoder that detects fault conditions (e.g., such as open or short circuits) and a patient user's companion device including a software application operable to implement algorithms for detecting faults and communication loss and alerting the patient user for safety and fail-safes of the medicine injection device.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: June 28, 2022
    Assignee: Companion Medical, Inc.
    Inventors: Sean Saint, Jack Pryor, Arnold Holmquist
  • Publication number: 20220172816
    Abstract: Disclosed are systems and techniques providing alternatives to traditional insulin dose calculators that involve little to no input from a patient user of a medicine injection device, including a fixed-dose titration therapy dose calculator and a streamlined dose calculator. In some aspects, a system for administering a medicine using a fixed-dose titration protocol includes an injection pen device in wireless communication with a mobile communication device comprising a software application to determine a recommended one or more fixed-dose sizes of the insulin based on (i) health data, including first glucose level of a patient user of the injection pen device that is measured prior to consumption of a meal and a second glucose level of the patient user that is measured within a predefined time period after consumption of the meal, and (ii) meal data, including a meal type of the meal and a meal size of the meal.
    Type: Application
    Filed: February 21, 2020
    Publication date: June 2, 2022
    Inventors: Michael Mensinger, Jasper Benke, Sean Saint, Eric Cohen, Jack Pryor, Haripriyan Hampapuram
  • Publication number: 20220054056
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: November 4, 2021
    Publication date: February 24, 2022
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, JR., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin, Victor Ha, Steve Masterson, Melissa A. Nicholas, John Nolting, James R. Petisce, Sean Saint, Vance Swanson, Kum Ming Woo
  • Publication number: 20220054055
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: November 4, 2021
    Publication date: February 24, 2022
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, JR., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin, Victor Ha, Steve Masterson, Melissa A. Nicholas, John Nolting, James R. Petisce, Sean Saint, Vance Swanson, Kum Ming Woo
  • Publication number: 20210290119
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: June 7, 2021
    Publication date: September 23, 2021
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, JR., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin, Victor Ha, Steve Masterson, Melissa A. Nicholas, John Nolting, James R. Petisce, Sean Saint, Vance Swanson, Kum Ming Woo
  • Patent number: 11045120
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: January 28, 2021
    Date of Patent: June 29, 2021
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, Jr., Victor Ha, Apurv Ullas Kamath, Aarthi Mahalingam, Steve Masterson, Melissa A. Nicholas, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Vance Swanson, Matthew D. Wightlin, Kum Ming Woo
  • Publication number: 20210169380
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Application
    Filed: January 25, 2021
    Publication date: June 10, 2021
    Inventors: Mark C. Brister, Steve Masterson, John Michael Dobbles, Michael Robert Mensinger, Sean Saint, Apurv Ullas Kamath
  • Patent number: 11026605
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: January 28, 2021
    Date of Patent: June 8, 2021
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, Jr., Victor Ha, Apurv Ullas Kamath, Aarthi Mahalingam, Steve Masterson, Melissa A. Nicholas, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Vance Swanson, Matthew D. Wightlin, Kum Ming Woo
  • Publication number: 20210138156
    Abstract: Systems, devices, and techniques are disclosed for administering and tracking medicine to patients and providing health management capabilities for patients and caregivers. In some aspects, an intelligent medicine administering system includes a medicine injection device having a multi-channel encoder that detects fault conditions (e.g., such as open or short circuits) and a patient user's companion device including a software application operable to implement algorithms for detecting faults and communication loss and alerting the patient user for safety and fail-safes of the medicine injection device.
    Type: Application
    Filed: January 25, 2021
    Publication date: May 13, 2021
    Inventors: Sean Saint, Jack Pryor, Arnold Holmquist
  • Patent number: 10980452
    Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
    Type: Grant
    Filed: November 3, 2020
    Date of Patent: April 20, 2021
    Assignee: DexCom, Inc.
    Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, Jr., Apurv Ullas Kamath, Steve Masterson, Aarthi Mahalingam, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Vance Swanson, Matthew D. Wightlin
  • Publication number: 20210093782
    Abstract: A portable infusion pump can communicate with glucose monitor, such as a continuous glucose monitor (CGM), to receive continuous feedback relating to a user's blood glucose level during insulin or other medicament therapy and can automatically deliver insulin to a user when the CGM data indicates a need for additional insulin. Due to potential unreliability in the correlation of the CGM data to the user's actual blood glucose level, risk mitigation can be employed to limit the amount of extra insulin that can be delivered by the pump in response to the CGM data.
    Type: Application
    Filed: December 14, 2020
    Publication date: April 1, 2021
    Inventors: Sean Saint, Michael Rosinko
  • Publication number: 20210098108
    Abstract: Methods, systems, and devices are disclosed for tracking delivery of medication. In one aspect, a medication delivery tracking device can interface with and be physically placed on a medication delivery pen device. The medication delivery tracking device can detect an occurrence of a delivery of a medication by the medication delivery pen device. In some implementations, the medication delivery tracking device can detect a dose amount of the medication delivered by the medication delivery pen device.
    Type: Application
    Filed: December 14, 2020
    Publication date: April 1, 2021
    Inventors: Sean Saint, Jack Pryor, Arnold Holmquist
  • Publication number: 20210046246
    Abstract: Systems, devices, and techniques are disclosed for administering and tracking medicine to patients and providing health management capabilities for patients and caregivers. In some aspects, an intelligent medicine administering system includes a medicine injection device having a multi-channel encoder that detects fault conditions (e.g., such as open or short circuits) and a patient user's companion device including a software application operable to implement algorithms for detecting faults and communication loss and alerting the patient user for safety and fail-safes of the medicine injection device.
    Type: Application
    Filed: May 8, 2019
    Publication date: February 18, 2021
    Inventors: Sean Saint, Jack Pryor, Arnold Holmquist
  • Patent number: D938457
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: December 14, 2021
    Assignee: Tandem Diabetes Care, Inc.
    Inventors: Michael Rosinko, Sean Saint, Jason Farnan, Shaun Buchanan